Published in Arthritis Rheum on December 01, 2012
Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken. Acta Neuropathol (2015) 0.94
Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications. Clin Exp Immunol (2014) 0.90
Immunotherapies for Immune-Mediated Myopathies: A Current Perspective. Neurotherapeutics (2016) 0.85
Mechanistic effects of IVIg in neuroinflammatory diseases: conclusions based on clinicopathologic correlations. J Clin Immunol (2014) 0.85
Inclusion body myositis. Neurol Clin (2014) 0.83
Efficacy of Intravenous Immunoglobulin in Neurological Diseases. Neurotherapeutics (2016) 0.82
Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies. Int J Mol Sci (2015) 0.79
αB-crystallin and HspB2 deficiency is protective from diet-induced glucose intolerance. Genom Data (2016) 0.75
A rare association of early-onset inclusion body myositis, rheumatoid arthritis and autoimmune thyroiditis: a case report and literature review. Funct Neurol (2013) 0.75
Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM. BMC Neurol (2016) 0.75
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol (2008) 3.59
Inflammatory muscle diseases. N Engl J Med (2015) 3.15
Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle. Brain (2008) 2.18
Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis. Ann Neurol (2007) 2.18
Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis. Brain (2009) 1.91
Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J Exp Med (2005) 1.79
Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease. J Clin Invest (2009) 1.63
Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain (2005) 1.63
Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Neurology (2006) 1.62
High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome. Biochem Biophys Res Commun (2007) 1.60
Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients. J Immunol (2005) 1.35
Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies. J Neurol (2011) 1.29
Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. Ann Neurol (2009) 1.29
Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues. Nat Clin Pract Neurol (2007) 1.28
Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst (2003) 1.26
Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations. Mol Genet Metab (2004) 1.26
Immunology of stiff person syndrome and other GAD-associated neurological disorders. Expert Rev Clin Immunol (2013) 1.24
Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Arch Neurol (2004) 1.16
GNE mutations in an American family with quadriceps-sparing IBM and lack of mutations in s-IBM. Neurology (2002) 1.15
Variable pathogenic potentials of mutations located in the desmin alpha-helical domain. Hum Mutat (2006) 1.14
Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene. J Bone Miner Res (2005) 1.10
Resveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1. Mol Med (2012) 1.09
Immune response modulation by curcumin in a latex allergy model. Clin Mol Allergy (2007) 1.09
Exome sequencing identifies titin mutations causing hereditary myopathy with early respiratory failure (HMERF) in families of diverse ethnic origins. BMC Neurol (2013) 1.07
A cross-sectional description of social capital in an international sample of persons living with HIV/AIDS (PLWH). BMC Public Health (2012) 1.07
Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study. BMC Neurol (2007) 1.07
TNF-alpha induces macroautophagy and regulates MHC class II expression in human skeletal muscle cells. J Biol Chem (2010) 1.05
Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol (2003) 1.04
Nursing and midwifery regulatory reform in east, central, and southern Africa: a survey of key stakeholders. Hum Resour Health (2013) 1.03
A series of West European patients with severe cardiac and skeletal myopathy associated with a de novo R406W mutation in desmin. J Neurol (2004) 1.03
Selective inhibition of iNOS attenuates trauma-hemorrhage/resuscitation-induced hepatic injury. J Appl Physiol (1985) (2008) 1.02
Does "asymptomatic" mean without symptoms for those living with HIV infection? AIDS Care (2009) 1.02
Activation of endoplasmic reticulum stress response following trauma-hemorrhage. Biochim Biophys Acta (2008) 1.02
Effect of human parathyroid hormone hPTH (1-34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Bone (2010) 1.02
Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. Am J Hum Genet (2002) 1.02
Inflammatory Muscle Diseases. N Engl J Med (2015) 1.01
Flutamide protects against trauma-hemorrhage-induced liver injury via attenuation of the inflammatory response, oxidative stress, and apopotosis. J Appl Physiol (1985) (2008) 0.99
Focus on increasing treatment self-efficacy to improve human immunodeficiency virus treatment adherence. J Nurs Scholarsh (2012) 0.98
Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy. Glycobiology (2005) 0.98
Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome. Brain (2006) 0.98
Practical considerations on the use of rituximab in autoimmune neurological disorders. Ther Adv Neurol Disord (2010) 0.98
Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity. Brain (2004) 0.97
In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy. Eur J Hum Genet (2008) 0.97
Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders. Neurology (2013) 0.97
Role of interleukin 10 during persistent infection with the relapsing fever Spirochete Borrelia turicatae. Am J Pathol (2007) 0.95
Nursing and midwifery regulation and HIV scale-up: establishing a baseline in East, Central and Southern Africa. J Int AIDS Soc (2013) 0.95
Expression of IFN-gamma-inducible chemokines in inclusion body myositis. J Neuroimmunol (2003) 0.95
Effect of estrogen on mitochondrial function and intracellular stress markers in rat liver and kidney following trauma-hemorrhagic shock and prolonged hypotension. Mol Med (2010) 0.94
Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy. Hum Genet (2003) 0.93
Female disclosure of HIV-positive serostatus to sex partners: a two-city study. Women Health (2010) 0.92
Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. Arch Neurol (2010) 0.92
HIV infection and antiretroviral therapy have divergent effects on mitochondria in adipose tissue. J Infect Dis (2012) 0.92
Brain gamma-aminobutyric acid changes in stiff-person syndrome. Arch Neurol (2005) 0.91
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity. J Clin Invest (2015) 0.91
Influence of aging and hemorrhage injury on Sirt1 expression: possible role of myc-Sirt1 regulation in mitochondrial function. Biochim Biophys Acta (2011) 0.91
A critical update on the immunopathogenesis of Stiff Person Syndrome. Eur J Clin Invest (2010) 0.91
Anosmin-1 involved in neuronal cell migration is hypoxia inducible and cancer regulated. Cell Cycle (2009) 0.91
Update on treatment of inclusion body myositis. Curr Rheumatol Rep (2013) 0.90
Shame, guilt, and stress: Community perceptions of barriers to engaging in prevention of mother to child transmission (PMTCT) programs in western Kenya. AIDS Patient Care STDS (2014) 0.89
Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record. Neurology (2003) 0.89
Immune mechanisms in chronic inflammatory demyelinating neuropathy. Neurology (2002) 0.89
Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study. J Peripher Nerv Syst (2010) 0.89
Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response. J Neuropathol Exp Neurol (2007) 0.89
A focused microarray to study human mitochondrial and nuclear gene expression. Biol Res Nurs (2008) 0.89
Suppression of activation and costimulatory signaling in splenic CD4+ T cells after trauma-hemorrhage reduces T-cell function: a mechanism of post-traumatic immune suppression. Am J Pathol (2009) 0.89
Macroautophagy as a pathomechanism in sporadic inclusion body myositis. Autophagy (2007) 0.88
Motor performance of young dystrophic mdx mice treated with long-circulating prednisolone liposomes. J Neurosci Res (2012) 0.88
Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis? Calcif Tissue Int (2009) 0.87
Interplay between inflammation and degeneration: using inclusion body myositis to study "neuroinflammation". Ann Neurol (2008) 0.87
Aging influences cardiac mitochondrial gene expression and cardiovascular function following hemorrhage injury. Mol Med (2010) 0.87
Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS One (2013) 0.87
Immunotherapy in autoimmune neuromuscular disorders. Lancet Neurol (2003) 0.86
Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis. J Neuroimmunol (2007) 0.86
The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): a small pilot study. J Neurol Sci (2013) 0.86
Hypoxia-induced alteration of mitochondrial genes in cardiomyocytes: role of Bnip3 and Pdk1. Shock (2010) 0.86
Prevalence, self-care behaviors, and self-care activities for peripheral neuropathy symptoms of HIV/AIDS. Nurs Health Sci (2010) 0.86
A comparison of fatigue scales in postpoliomyelitis syndrome. Arch Phys Med Rehabil (2006) 0.86
Electrophysiologic correlations with clinical outcomes in CIDP. Muscle Nerve (2010) 0.85
A "nema" of hope in the treatment of late-onset nemaline myopathy. Neurology (2008) 0.85
Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells. Ann Neurol (2007) 0.84
Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry (2010) 0.84
Changes in the histomorphometric and biomechanical properties of the proximal femur of ovariectomized rat after treatment with the phytoestrogens genistein and equol. Planta Med (2009) 0.84
The prevention of mother-to-child transmission of HIV cascade analysis tool: supporting health managers to improve facility-level service delivery. BMC Res Notes (2014) 0.84
Pro-inflammatory cytokines and motor neuron dysfunction: is there a connection in post-polio syndrome? J Neurol Sci (2002) 0.84
Musculoskeletal response to whole-body vibration during fracture healing in intact and ovariectomized rats. Calcif Tissue Int (2010) 0.83
Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination: long-term protective effects and enhanced efficacy of methylprednisolone formulations. Exp Neurol (2008) 0.83
Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design. J Neurol (2011) 0.83
Gene expression profiling in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol (2004) 0.83